Otsuka Philippines celebrates 15th year

From left: Dr. Dai Hyon Yu, chairman of Korea OIAA Co. Ltd; Leopoldo Dimerin, president of Otsuka Philippines; and Kazushi Takemoto, OPPI vice president, offer a toast to Otsuka Philippines’ 15th year.

MANILA, Philippines - Otsuka Philippines, one of the leading Japanese pharmaceutical companies in the Philippines, celebrated its 15th anniversary celebration last Dec. 4 at the Marriott Hotel.

Otsuka Philippines began treading the path of excellence with its humble beginnings in 1997. While it only had 65 employees at first, it stood strong by its promise to bring research-based products aimed at improving the health of Filipinos.

Today, Otsuka is the leading Japanese pharmaceutical firm in the Philippines, strongly bound by dedicated people with value for quality and the constant pursuit of “out of the box” thinking. Since then, Otsuka Philippines has come far from its humble beginnings.

True to its motto of “People creating new products for better health worldwide,” Otsuka Philippines never ceased to bring forth a line of well-researched pharmaceutical products addressing cardiovascular, neurological and gastrointestinal ailments, as well as products in the “nutraceutical” field.  

“Fifteen years did not go by without its trials, but these were hurdles we had managed to leap over to bring us where we are today,” said Leopoldo Dimerin, president and general manager of Otsuka Philippines.

“We are a well-positioned institution with a clear aim of providing ‘First in Class and Best in Class’ products for the healthcare of the Filipino people,” he added.

To give back to Filipinos for its success through the years, Otsuka pledged its commitment with “Otsuka Cares,” its social responsibility group.

Gracing the event were Dr. Dai Hyon Yu, chairman of Korea OIAA Co. Ltd. The event ended with a ceremonial toast led by Dai, Dimerin, and Kazushi Takemoto, OPPI vice president.

“You can expect that in the coming years we will continue the transformation process oriented toward increasing our innovative capability, improving operational efficiency and valuing our customers,” Dimerin said.

“That’s how we set ourselves apart from the other pharmaceutical companies and facilitate a growth faster than the market,” he added.

Show comments